Intercept Pharmaceuticals
development novel liver therapeutics
- B2B
About Intercept Pharmaceuticals
development and commercialization of novel therapeutics targeting rare and serious liver diseases such as primary biliary cholangitis and severe alcohol-associated hepatitis
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Morristown, New Jersey, United States
- Founded
- 2002
- Revenue
- $40.2M – $318MTamtam estimate
- Website
- interceptpharma.com
Intercept Pharmaceuticals at a glance
Intercept Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Morristown, New Jersey, United States.
Intercept Pharmaceuticals was founded in 2002.
Intercept Pharmaceuticals has 251–1,000 employees.
Intercept Pharmaceuticals's revenue is $40.2M – $318M (Tamtam estimate).
Selling to companies like Intercept Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies